Latest Period
Q1 2026
Security Snapshot
Profound Medical Corp. - Common Shares (PROF) Institutional Ownership
CUSIP: 74319B502
13F Institutional Holders and Ownership History from Q4 2019 to Q1 2026
Institutions Reporting
57
Shares (Excl. Options)
16,337,804
Price
$6.48
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
- Type / Class
- Equity / Common Shares
- Symbol
- PROF on Nasdaq
- Shares outstanding
- 29,881,634
- Price per share
- $6.55
- All holders as of 31 Mar 2026
- Q1 2026
- Total 13F shares
- 16,337,804
- Total reported value
- $105,590,763
- % of total 13F portfolios
- 0%
- Share change
- +280,516
- Value change
- -$569,539
- Number of holders
- 57
- Price from insider filings
- $6.55
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Key facts
- PROF - Profound Medical Corp. - Common Shares is tracked under CUSIP 74319B502.
- 57 institutions reported positions in Q1 2026.
- 1 significant owner is listed from Schedule 13D/13G reporting.
Change
- Holder count moved from 63 to 57 between Q4 2025 and Q1 2026.
- Reported value moved from $126,309,609 to $105,590,763.
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Form 13F
Open SEC Evidence
Latest holder context comes from 57 institutions filings for Q1 2026.
Security key
74319B502
Latest holder period
Q1 2026
13F holders
57
13D/G owners
1
CIK / CUSIP context first
Open Q1 2026 holders
PROF full holder history
Profound Medical Corp. SEC filings
Profound Medical Corp. company facts
Profound Medical Corp. insider transactions
Broader feeds
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 74319B502:
Significant Owners of Profound Medical Corp. - Common Shares (PROF) based on Schedule 13D/G filings
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| GAGNON SECURITIES LLC | 11% | $15,796,627 | 3,346,743 | Neil Gagnon | 31 Dec 2024 |
As of 31 Mar 2026, 57 institutional investors reported holding 16,337,804 shares of Profound Medical Corp. - Common Shares (PROF). This represents 55% of the company’s total 29,881,634 outstanding shares.
Top 25 Institutional Shareholders
The largest institutional shareholders of Profound Medical Corp. - Common Shares (PROF) together control 52% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| FIL Ltd | 7.8% | 2,340,000 | +6.4% | 0.01% | $15,163,203 |
| GAGNON SECURITIES LLC | 6.5% | 1,944,324 | +0.01% | 2.9% | $12,599,219 |
| ROYCE & ASSOCIATES LP | 3.7% | 1,116,348 | +13% | 0.07% | $7,142,188 |
| Timelo Investment Management Inc. | 3.7% | 1,114,967 | +14% | 9.9% | $7,224,986 |
| Gagnon Advisors, LLC | 3.2% | 962,186 | 0% | 4.6% | $6,234,965 |
| LETKO, BROSSEAU & ASSOCIATES INC | 3.2% | 953,175 | -1.8% | 0.1% | $6,085,437 |
| Rosalind Advisors, Inc. | 2.8% | 828,118 | -23% | 2.2% | $5,366,205 |
| Z3 Capital Partners, LLC | 2.7% | 817,991 | -0.12% | 1.3% | $5,300,582 |
| MMCAP International Inc. SPC | 2.5% | 745,152 | +40% | 0.42% | $4,828,585 |
| ARDSLEY ADVISORY PARTNERS LP | 1.9% | 575,000 | +28% | 0.57% | $3,726,000 |
| Ring Mountain Capital, LLC | 1.7% | 511,105 | +13% | 1.8% | $3,312,000 |
| ROYAL BANK OF CANADA | 1.7% | 493,060 | +4.2% | 0% | $3,195,000 |
| Lagoda Investment Management, L.P. | 1.5% | 441,015 | 1.8% | $2,857,777 | |
| First Eagle Investment Management, LLC | 1.1% | 322,707 | +3.2% | 0% | $2,091,141 |
| Velan Capital Investment Management LP | 0.96% | 285,710 | 0% | 1.2% | $1,851,401 |
| PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE | 0.92% | 276,001 | 2.4% | $1,788,486 | |
| DAFNA Capital Management LLC | 0.88% | 263,005 | -7.9% | 0.39% | $1,704,272 |
| Bleichroeder LP | 0.85% | 254,753 | 0% | 0.29% | $1,650,799 |
| FORMULA GROWTH LTD | 0.81% | 241,138 | +19% | 0.71% | $1,562,574 |
| Dauntless Investment Group, LLC | 0.81% | 240,739 | +219% | 4.4% | $1,559,989 |
| NATIONAL BANK OF CANADA /FI/ | 0.73% | 217,175 | +15% | 0% | $1,342,133 |
| THOMPSON DAVIS & CO., INC. | 0.72% | 215,785 | -0.44% | 0.93% | $1,398,287 |
| CM Management, LLC | 0.59% | 175,000 | +119% | 0.95% | $1,134,000 |
| RAYMOND JAMES FINANCIAL INC | 0.5% | 150,157 | +11% | 0% | $973,018 |
| TD Waterhouse Canada Inc. | 0.48% | 143,041 | +85% | 0% | $902,046 |
Institutional Holders of Profound Medical Corp. - Common Shares (PROF) across Reporting Periods
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q1 | 16,337,804 | $105,590,763 | -$569,539 | $6.48 | 57 |
| 2025 Q4 | 16,057,288 | $126,309,609 | +$31,389,798 | $7.87 | 63 |
| 2025 Q3 | 11,063,194 | $54,283,775 | -$7,406,922 | $4.89 | 43 |
| 2025 Q2 | 12,482,340 | $73,650,616 | -$2,042,016 | $5.90 | 44 |
| 2025 Q1 | 12,825,851 | $73,303,109 | -$7,205,786 | $5.82 | 48 |
| 2024 Q4 | 13,763,555 | $102,960,287 | +$30,141,003 | $7.51 | 51 |
| 2024 Q3 | 9,406,781 | $74,869,184 | -$1,117,706 | $7.96 | 42 |
| 2024 Q2 | 9,510,240 | $80,047,787 | -$132,453 | $8.39 | 37 |
| 2024 Q1 | 9,500,142 | $80,114,995 | +$2,238,848 | $8.53 | 39 |
| 2023 Q4 | 9,251,176 | $77,759,535 | +$10,244,275 | $8.49 | 45 |
| 2023 Q3 | 7,489,374 | $75,450,155 | -$1,487,679 | $10.20 | 30 |
| 2023 Q2 | 7,634,234 | $98,724,050 | -$1,129,044 | $13.01 | 29 |
| 2023 Q1 | 7,726,121 | $71,704,219 | -$6,964,776 | $9.29 | 30 |
| 2022 Q4 | 8,472,949 | $91,726,796 | +$3,083,523 | $10.89 | 33 |
| 2022 Q3 | 8,745,198 | $35,381,959 | -$177,655 | $4.04 | 30 |
| 2022 Q2 | 8,675,590 | $63,032,248 | -$3,670,846 | $7.29 | 34 |
| 2022 Q1 | 9,402,835 | $84,635,691 | -$3,611,432 | $9.00 | 41 |
| 2021 Q4 | 9,774,988 | $109,777,858 | -$2,915,423 | $11.24 | 44 |
| 2021 Q3 | 8,722,358 | $127,589,352 | -$1,309,423 | $14.64 | 46 |
| 2021 Q2 | 8,722,951 | $142,593,346 | -$126,994 | $16.36 | 46 |
| 2021 Q1 | 8,673,835 | $174,440,609 | +$8,178,699 | $20.14 | 52 |
| 2020 Q4 | 8,182,487 | $168,377,436 | +$26,332,305 | $20.56 | 53 |
| 2020 Q3 | 7,009,150 | $123,510,789 | +$42,298,243 | $17.64 | 44 |
| 2020 Q2 | 4,612,581 | $78,146,000 | -$131,017 | $16.94 | 33 |
| 2020 Q1 | 4,764,927 | $46,182,000 | +$27,289,444 | $9.74 | 31 |
| 2019 Q4 | 1,948,600 | $21,824,000 | +$21,824,000 | $10.98 | 16 |